HomeHealthcare & Life SciencesPharmaceuticals Myasthenia Gravis Treatment Market

Global Myasthenia Gravis Treatment Market Size & Outlook, 2025-2033


Global Myasthenia Gravis Treatment Market Insights

  • According to Reed Intelligence analysis, the Global Myasthenia Gravis Treatment Market size was USD 2109.99 Million in 2024 and is projected to reach USD 5032.14 Million by 2033.
  • The Global market is projected to grow at a CAGR of 10.1% between 2026 and 2033.
  • By segment, Ocular MG  emerged as the largest By Type in terms of market size in 2024.
  • Congenital MG  is anticipated to remain the most attractive By Type segment, recording the fastest growth during the forecast period.

Other Key Findings


  • By 2033, United States is expected to lead the global Myasthenia Gravis Treatment Market in terms of market size.
  • Within Global, North America is projected to dominate the regional Myasthenia Gravis Treatment Market size by 2033.
  • Middle East and Africa is identified as the fastest-growing market in Global, anticipated to reach USD 552.91 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 2109.99 Million
Market Size In 2033 USD 5032.14 Million
Largest segment Ocular MG 
Units Revenue in USD Million
CAGR 10.1% (2025-2033)
Segmnetation Covered
Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Middle East and Africa
  5. LATAM
By Type
  1. Ocular MG 
  2. Congenital MG 
  3. Transient Neonatal MG
By Treatment
  1. Medication 
  2. Surgery 
  3. Autologous Hematopoietic Stem Cell Transplantation (HSCT) 
  4. Plasmapheresis and Intravenous Immunoglobulin 
  5. Others
By End-User
  1. Hospitals 
  2. Clinics 
  3. Academic Research Institutes 
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports